Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2014

Mar 14, 2014

33899_dirs_2014-03-14_f52eda51-8082-4bb5-ae36-716898ceb2ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2014-03-12

Reporting Person: BONDROFF BARRY B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-05 Common Stock A 1622 $0.00 Acquired 23213 Direct
2013-02-19 Common Stock A 750 $0.00 Acquired 23963 Direct
2014-03-12 Common Stock S 2500 $26.9376 Disposed 21463 Direct

Footnotes

F1: These securities were awarded by the Company in transactions exempt from Section 16(b) of the Exchange Act.

F2: The price in column 4 is a weighted average price. The prices actually received ranged from $26.90 to $27.01. The reporting person undertakes to provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.